US2004058398A1PendingUtilityA1

Pancreatic progenitor cells and methods for isolating the same

Priority: Dec 16, 1998Filed: Sep 26, 2003Published: Mar 25, 2004
Est. expiryDec 16, 2018(expired)· nominal 20-yr term from priority
A61P 3/00A61K 38/1825A01K 2227/105C12N 5/0672C12N 2830/008C12N 15/8509C07K 16/18A61K 38/1808G01N 33/566C12N 2503/00A61P 1/16A01K 2267/0325A61K 48/00A01K 67/0275C12N 2501/117C07K 2319/30A01K 2267/03A01K 2217/05C12N 2501/11G01N 33/5005A61P 1/18A01K 67/0271C12N 2517/02C12N 5/0676C12N 5/0678A61K 39/00
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides animal models, where the ectopic expression of KGF, EGF, or both is under the control of a pancreas-specific promoter, e.g., the insulin promoter. The expression of KGF in the ins-KGF pancreatic islets of Langerhans results in enlarged islets, with substantial proliferation of duct cells within the islet mass, and the presence of albumin and alpha-fetoprotein-producing hepatocytes in the islets of the ins-KGF pancreata. The compositions and methods disclosed are useful for identifying and isolating pancreatic stem/progenitor cells, including a common stem/progenitor to liver cells and pancreatic cells.

Claims

exact text as granted — not AI-modified
1 . A substantially pure population of viable pancreatic progenitor cells characterized by expression of PDX-1 and able to differentiate into glucose-responsive, insulin-secreting cells.  
     
     
         2 . The substantially pure population of  claim 1 , wherein a subset of the population of cells expresses insulin.  
     
     
         3 . A method of isolating pancreatic progenitor cells comprising: 
 a) contacting pancreatic tissue with an antibody that binds to PDX-1;    b) detecting binding of the antibody; and    c) isolating the cells that bind to the antibody,    wherein the isolated cells are pancreatic progenitor cells.    
     
     
         4 . The method of  claim 3 , wherein the pancreatic tissue comprises pancreatic ductal epithelial cells.  
     
     
         5 . The method of  claim 4 , wherein the pancreatic ductal epithelial cells are found in the perilumenal and lumenal locations.  
     
     
         6 . The method of  claim 3 , wherein a subset of the isolated cells also express insulin.

Join the waitlist — get patent alerts

Track US2004058398A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.